Humana Stock News

Bragar Eagel & Squire, P.C. Litigation Attorney  Brandon Walker  Encourages Investors Who Suffered Losses In Humana (HUM) To Contact Him Directly To Discuss Their Options

Humana (HUM) Q2 Revenue Rises 10%

Humana Inc. (NYSE:HUM ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Celeste Marie Mellet - Chief Financial Officer George Renaudin - President of Insurance James A. Rechtin - President, CEO & Director Lisa M.

U.S. equities were mixed at midday as the market responded to the U.S. economy growing more than expected in the second quarter while waiting for today's decision by the Federal Reserve on interest rates. The S&P 500 and Nasdaq gained, but the Dow Jones Industrial Average fell.

Humana (HUM) shares took off Wednesday when the health insurer boosted its guidance as it sees fewer losses of Medicare Advantage customers than previously thought.

Humana's stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare Advantage business.

Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher medical costs that have plagued the sector, sending its shares up nearly 6% in premarket trading.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2025 (2Q25) versus the quarter ended June 30, 2024 (2Q24) and for the six months ended June 30, 2025 (YTD 2025) versus the six months ended June 30, 2024 (YTD 2024) as noted in the tables below.   Consolidated income before inco...